CBSTQ (Cannabist Company Holdings) 3-Year EBITDA Growth Rate: 0.00% (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cannabist Company Holdings 3-Year EBITDA Growth Rate?

Cannabist Company Holdings CBSTQ 3-Year EBITDA Growth Rate is 0.00% as of Sep. 2025. The stock has 3 warning signs investors should review. Among 810 Drug Manufacturers companies, Cannabist Company Holdings ranks worse than 123456.67% on this metric.

Cannabist Company Holdings's EBITDA per Share for the three months ended in Sep. 2025 was $0.02.

During the past 12 months, Cannabist Company Holdings's average EBITDA Per Share Growth Rate was -146.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Cannabist Company Holdings  (OTCPK:CBSTQ) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Cannabist Company Holdings 3-Year EBITDA Growth Rate Related Terms

CBSTQ vs OWPC, AYURF, PNXP: 3-Year EBITDA Growth Rate Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabist Company Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabist Company Holdings 3-Year EBITDA Growth Rate vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabist Company Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Cannabist Company Holdings's 3-Year EBITDA Growth Rate falls into.


Cannabist Company Holdings 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Cannabist Company Holdings (CBSTQ) has a 3-Year EBITDA Growth Rate of 0.00% as of Sep. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Cannabist Company Holdings and its competitors. According to the industry distribution chart, Cannabist Company Holdings ranks #999999 out of 810 companies in the Drug Manufacturers industry.
Is Cannabist Company Holdings' 3-Year EBITDA Growth Rate too high?
Cannabist Company Holdings' current 3-Year EBITDA Growth Rate is 0.00%. Based on the distribution chart, Cannabist Company Holdings ranks #999999 out of 810 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Cannabist Company Holdings' 3-Year EBITDA Growth Rate compare to OWPC and AYURF?
According to the Drug Manufacturers industry distribution chart, Cannabist Company Holdings ranks #999999 out of 810 companies for 3-Year EBITDA Growth Rate. This places Cannabist Company Holdings in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 8.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Drug Manufacturers company?
The median 3-Year EBITDA Growth Rate among Drug Manufacturers companies is 8.85, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Cannabist Company Holdings and its competitors. For the Drug Manufacturers industry, the median 3-Year EBITDA Growth Rate is 8.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabist Company Holdings's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabist Company Holdings stock overvalued right now?
Based on GuruFocus' analysis, Cannabist Company Holdings (CBSTQ) is currently considered Possible Value Trap. The stock's GF Value™ is $0.15, compared to a current price of $0.00 — trading 99.9% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Cannabist Company Holdings (CBSTQ), the current 3-Year EBITDA Growth Rate is 0.00% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannabist Company Holdings Business Description

Address 321 Billerica Road, Suite 204, Chelmsford, MA, USA, 01824
Cannabist Company Holdings Inc through its subsidiaries, operates as a cultivator, manufacturer, and provider of medical and adult-use cannabis products. Some of its products are vaporization oil, sublingual tinctures, lotions, hard-pressed tablets, and suppositories, among others which are marketed through brands like Classix, dreamt, Triple Seven, Amber, Press, Heady, and Seed and Strain. The company operates its businesses in California, Colorado, Delaware, Illinois, Maryland, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, Virginia, and West Virginia.